Skeletal effects of cyclosporin A are gender related in rats

Endocrinology

Volumn 144, Issue 1, 2003, Pages 40-49

  Erben, Reinhold G ^a   Brunner, Katrin S ^a   Breig, Bianca ^a   Eberle, Johannes ^a   Goldberg, Michel ^a   Hofbauer, Lorenz C ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; ESTRADIOL; SEX HORMONE;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MASS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG METABOLISM; FEMALE; GONADECTOMY; HORMONE METABOLISM; LIVER; MALE; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; RAT; SENESCENCE; SEX DIFFERENCE; SKELETON;

AMINO ACIDS; ANIMALS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; CALCIUM; CYCLOSPORINE; ESTRADIOL; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MALE; ORCHIECTOMY; OSTEOCALCIN; OSTEOPOROSIS; OVARIECTOMY; RATS; RATS, INBRED F344; SEX CHARACTERISTICS; SPINE; TESTOSTERONE; TIBIA;

EID: 0037225365     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220513     Document Type: Article

References (44)

1. Borel JF, Feurer C, Gubler HU, Stähelin H 1976 Biological effects of cyclosporin A: A new antilymphocytic agent. Agents Actions 6:468-475
2. Bierer BE 1994 Cyclosporin A, FK506, and rapamycin: Binding to immunophilins and biological action. Chem Immunol 59:128-155
3. Ho S, Clipstone N, Timmermann L, Northrop J, Graef I, Fiorentino D, Nourse J, Crabtree GR 1996 The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 80:S40-S45
4. Epstein S 1996 Post-transplantation bone disease: The role of immunosuppressive agents and the skeleton. J Bone Miner Res 11:1-7
5. Lukert BP, Raisz LG 1990 Glucocorticoid-induced osteoporosis:pathogenesis and management. Ann Intern Med 112:352-364
6. Shane E, Rivas MC, Silverberg SJ, Kim TS, Staron RB, Bilezikian JP 1993 Osteoporosis after cardiac transplantation. Am J Med 94:257-264
7. Thiébaud D, Krieg MA, Gillard-Berguer D, Jacquet AF, Goy JJ, Burckhardt P 1996 Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest 26:549-555
8. Ebeling PR, Thomas DM, Erbas B, Hopper JL, Szer J, Grigg AP 1999 Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. J Bone Miner Res 14:342-350
9. McIntyre HD, Menzies B, Rigby R, Perry Keene DA, Hawley CM, Hardie IR 1995 Long-term bone loss after renal transplantation: Comparison of immunosuppressive regimens. Clin Transpl 9:20-24
10. Briner VA, Thiel G, Monier-Faugere M-C, Bognar B, Landmann J, Kamber V, Malluche HH 1995 Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1, 25 vitamin D levels two years after kidney transplantation. Transplantation 59:1393-1400
11. Aroldi A, Tarantino A, Montagnino G, Cesana B, Cocucci C, Ponticelli C 1997 Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients - A prospective study. Transplantation 63:380-386
12. Parry RG, Jackson J, Stevens JM, Higgins B, Altmann P 1998 Long-term bone densitometry post-renal transplantation in patients treated with either cyclosporin or prednisolone. Nephrol Dial Transplant 13:531-532
13. Cueto-Manzano AM, Konel S, Hutchison AJ, Crowley V, France MW, Freemont AJ, Adams JE, Mawer B, Gokal R 1999 Bone loss in long-term renal transplantation: Histopathology and densitometry analysis. Kidney Int 55:2021-2029
14. Westeel FP, Mazouz H, Ezaitouni F, Hottelart C, Ivan C, Fardellone P, Brazier M, El Esper I, Petit J, Achard JM, Pruna A, Fournier A 2000 Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation. Kidney Int 58:1788-1796
15. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S 1988 Cyclosporin-A in vivo produces severe osteopenia in the rat: Effect of dose and duration of administration. Endocrinology 123:2571-2577
16. 3 modifies cyclosporine-induced bone loss. Calcif Tissue Int 47:152-157
17. Erben RG, Stangassinger M, Gärtner R 1998 Skeletal effects of low-dose cyclosporin A in aged male rats: Lack of relationship to serum testosterone levels. J Bone Miner Res 13:79-87
18. Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S 1989 Cyclosporin A in the oophorectomized rat: Unexpected severe bone resorption. J Bone Miner Res 4:393-398
19. Joffe I, Katz I, Jacobs T, Stein B, Takizawa M, Liu C, Berlin J, Epstein S 1992 17 beta-estradiol prevents osteopenia in the oophorectomized rat treated with cyclosporin-A. Endocrinology 130:1578-1586
20. Del Pozo E, Lippuner K, Ruch W, Casez JP, Payne T, MacKenzie A, Jaeger P 1995 Dffferent effects of cyclosporin A on bone remodeling in young and adult rats. Bone 16(Suppl):271S-275S
21. Klein L, Lemel MS, Wolfe MS, Shaffer J 1994 Cyclosporin A does not affect the absolute rate of cortical bone resorption at the organ level in the growing rat. Catcif Tissue Int 55:295-301
22. Orcel P, Bielakoff J, Modrowski D, Miravet L, de Vernejoul MC 1989 Cyclosporin A induces in vivo inhibition of resorption and stimulation of formation in rat bone. J Bone Miner Res 4:387-391
23. Colwell A, Russell RGG, Eastell R 1993 Factors affecting the assay of urinary 3-hydroxy pyridinium cross-links of collagen as markers of bone resorption. Eur J Clin Invest 23:341-349
24. Erben RG, Eberle J, Stahr K, Goldberg M 2000 Androgen deficiency induces high turnover osteopenia in aged male rats: A sequential histomorphometric study. J Bone Miner Res 15:1085-1098
25. Vandenput L, Ederveen AG, Erben RG, Stahr K, Swinnen JV, Van Herck E, Verstuyf A, Boonen S, Bouillon R, Vanderschueren D 2001 Testosterone prevents orchidectomy-induced bone loss in estrogen receptor-alpha knockout mice. Biochem Biophys Res Commun 285:70-76
26. Molpeceres J, Chacón M, Berges L, Pedraz JL, Guzmán M, Aberturas MR 1998 Age and sex dependent pharmacokinetics of cyclosporine in the rat after a single intravenous dose. Int J Pharm 174:9-18
27. Molpeceres J, Chacon M, Guzman M, Aberturas MR, Berges L 2000 Dependency of cyclosporine tissue distribution and metabolism on the age and gender of rats aftera single intravenous dose. Int J Pharm 197:129-141
28. Jäger W, Correia MA, Bornheim LM, Mahnke A, Hanstein WG, Xue L, Benet LZ 1999 Ethynylestradiol-mediated induction of hepatic CYP3A9 in female rats: Implication for cyclosporine metabolism. Drug Metab Dispos 27:1505-1511
29. Tominaga K, Yamauchi A, Shuto H, Niizeki M, Makino K, Oishi R, Kataoka Y 2001 Ovariectomy aggravates convulsions and hippocampal gamma-aminobutyric acid inhibition induced by cyclosporin A in rats. Eur J Pharmacol 430:243-249
30. Molpeceres J, Chacon M, Aberturas MR, Guzman M, Diez ML, Rodriguez-Puyol M 2001 Effect of gonadectomy on cyclosporine pharmacokinetics in male and female rats. Pharmazie 56:78-82
31. Kahan BD, Kramer WG, Wideman C, Flechner SM, Lorber MI, Van Buren CT 1986 Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay. Transplantation 41:459-464
32. Hunt CM, Westerkam WR, Stave GM 1992 Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol 44:275-283
33. Harris RZ, Benet LZ, Schwartz JB 1995 Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50:222-239
34. Gleiter CH, Gundert-Remy U 1996 Gender differences in pharmacokinetics. Eur J Drug Metab Pharmacokinet 21:123-128
35. Seethalakshmi L, Flores C, Carboni AA, Bala R, Diamond DA, Menon M 1990 Cyclosporine: Its effects on testicular function and fertility in the prepubertal rat. J Androl 11:17-24
36. Krueger BA, Trakshel GM, Sluss PM, Maines MD 1991 Cyclosporin-mediated depression of luteinizing hormone receptors and heme biosynthesis in rat testes: A possible mechanism for decrease in serum testosterone. Endocrinology 129:2647-2654
37. Handelsman DJ, McDowell IF, Caterson ID, Tiller DJ, Hall BM, Turtle JR 1984 Testicular function after renal transplantation: Comparison of cyclosporin A with azathioprine and prednisone combination regimes. Clin Nephrol 22:144-148
38. Handelsman DJ, McDowell IF, Caterson ID, Tiller DJ, Hall BM, Turtle JR 1984 Ovarian function after renal transplantation: Comparison of cyclosporin A with azathioprine and prednisone combination regimens. Br J Obstet Gynaecol 91:802-807
39. Schmidt JB, Gebhart W, Kopsa H, Spona J 1986 Does cyclosporin A influence sex hormone level? Exp Clin Endocrinol 88:207-211
40. Peces R, de la Torre M, Urra JM 1994 Pituitary-testicular function in cyctosporin-treated renal transplant patients. Nephrol Dial Transplant 9:1453-1455
41. Ferraccioli G, Casatta L, Bartoli E 1996 Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy. J Rheumatol 23:1539-1542
42. Buchinsky FJ, Ma YF, Mann GN, Rucinski B, Bryer HP, Romero DF, Jee WSS, Epstein S 1996 T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia. Endocrinology 137:2278-2285
43. Ferron GM, Jusko WJ 1998 Spedes- and gender-related differences in cyclosporine/prednisolone/sirolimus interactions in whole blood lymphocyte proliferation assays. J Pharmacol Exp Ther 286:191-200
44. Ferron GM, Pyszczynski NA, Jusko WJ 1998 Gender-related assessment of cyclosporine/prednisolone/sirolimus interactions in three human lymphocyte proliferation assays. Transplantation 65:1203-1209